INTRODUCTION
Beet necrotic yellow vein virus (BNYVV) is a quadripartite plus-stranded RNA virus that is transmitted in the soil by the fungus Polymyxa betae and which induces rhizomania disease of sugarbeet (Tamada, 1975) . In naturally infected sugarbeet roots all four genome components of the virus are invariably present (Koenig et al., 1986) , but the two smallest RNA components, RNA-3 and RNA-4, may undergo deletion or disappear from isolates passaged serially by mechanical inoculation of Chenopodium quinoa leaves (Bouzoubaa et al., 1985; Burgermeister et al., 1986; Kuszala et al., 1986) . Results of attempts to transmit such isolates back to sugarbeet roots with P. betae suggest that one or both of the small RNAs play a role in vector transmission (Lemaire et at., 1988) but more detailed studies of their functions have been hampered by the difficulty of isolating and maintaining isolates of the desired RNA-3 and RNA-4 composition in C. quinoa (unpublished observations).
Development of efficient in vitro run-off transcription systems based on cloned bacteriophage promoters and purified Escherichia coli or bacteriophage RNA polymerase has led to the production of biologically active RNA transcripts from eDNA clones of a number of plant and animal viruses (Ahlquist et al., 1984; Mitzutani & Colonno, 1985; Loesch-Fries et al., 1985; Dasmahapatra et al., 1986; Dawson et al., 1986; van der Werf et al., 1986; Meshi et al., 1986; Langereis et al., 1986; Rice et al., 1987) . Such transcripts represent well-defined and stable inocula which are, furthermore, easily manipulated at the eDNA level by recombinant eDNA techniques. In this paper we describe the construction of biologically active transcripts of BNYVV RNA-3 and RNA-4 using a bacteriophage T7 in vitro transcription system. The effect of extraneous 5' non-viral nucleotide sequences of different lengths on the biological activity of RNA-3 transcripts was also examined.
METHODS
the helper phage VCSM 13 (Stratagene). Plasmid pB31 (2-1774) was constructed by fusing the almost full-length BNYVV RNA-3 eDNA insert from pBF11 (Bouzoubaa et aL, 1985) , flanked by SalI and HindlII restriction sites, between the SalI and HindlII polylinker restriction sites of pBS (-) . Note that the pB31(2-1774) insert contains a Y-terminal 14 residue dC homopolymer tract introduced during construction of pBF 11 (Bouzoubaa et al., 1985) . A recombinant cDNA plasmid containing the RNA-3 Y-terminal region without the homopolymer tract was prepared by priming first-strand eDNA synthesis on RNA from BNYVV isolate F13 (Ziegler et al., 1985) with the synthetic oligodeoxynucleotide TCATAGTGGATGACGAGACCGGT, which is complementary to nucleotides (nt) 797 to 819 of RNA-3 (Bouzoubaa et al., 1985 . Second-strand DNA synthesis was primed with the synthetic oligodeoxynucleotide AAATTCAAAATTTACC, corresponding to nt 2 to 17 of plus-strand RNA-3. The double-stranded eDNA was inserted into the HinclI site of pUC9 to give pB30(2-800)PUC, where PUC indicates that the vector was pUC9 rather than pBS(-). The small EcoRI fragment of pB30(2-800)PUC, extending from the polylinker EcoRI site preceding the cDNA insert to nt 377 of the insert, was purified from a low melting point agarose gel and used to replace the corresponding EcoRI fragment from pB31(2-1774) to give pB33(2-1774). Plasmid pB35(2-1774) was obtained by oligodeoxynucleotide-directed mutagenesis (Zoller & Smith, 1982) of single-stranded pB33(2-1774) with the synthetic oligodeoxynucleotide 5'-ATTTTGAATTTCTA-TAGTGAGT-Y, which is complementary to nt 2 to 12 of RNA-3 and the Y-terminal portion of the T7 promoter (bold type). Recombinant cDNA clones with the desired structure were identified by colony hybridization using the 5'-3zp-labelled mutagenic oligodeoxynucleotide as probe (Zoller & Smith, 1982) . pB35ABA was obtained by cutting pB35(2-1774) with BamHI and AccI, filling in sticky ends of the plasmid DNA with the Klenow fragment of DNA polymerase I in the presence of dNTPs and religation, pB35AEA was obtained by cutting pB35(2-1774) with EcoRI and AccI, followed by fill-in of sticky ends and religation.
A transcription vector, pB44(2-1467) containing all but the first residue of the BNYVV RNA-4 sequence, was also constructed. Double-stranded cDNA encompassing the RNA-4 5'-terminal region was prepared by priming first-strand eDNA synthesis with a synthetic oligodeoxynucleotide complementary to nt 337 to 358 of RNA-4 and second-strand synthesis with a synthetic oligodeoxynucleotide corresponding to nt 2 to 17. The double-stranded eDNA was cloned into the Sinai site of pBS(-) to give pB40(2-358), in which the orientation of the eDNA is such that the 5' terminus of the sense strand is adjacent to the polylinker EcoRI site. A BamHI-SalI fragment extending from nt 359 of the insert sequence to the polylinker SalI site following the 3'-poly(A) tail was excised from pBF15, an RNA-4 recombinant plasmid obtained previously (Bouzoubaa et al., 1985) . The fragment was inserted between the BamHI site and the polylinker SalI site of pB40(2-358) to yield pB44(2-1467). The structures of the various intermediates and the final transcription vectors were verified by restriction endonuclease mapping and sequence analysis. Cloning procedures and other recombinant DNA techniques were essentially as described by Maniatis et aL (1982) and Bouzoubaa et al. (1987) .
In vitro transcription. In a final volume of 35 I11 the transcription reaction mixture contained 40 mM-Tris-HC1 pH 8, 8 mM-MgC12, 2 mi-spermidine, 50 mi-NaC1, 10 mM-dithiothreitol, 500 IXM each of ATP, UTP and CTP, 25 lar~-GTP, 500 txi-mTGpppG (Pharmacia), 80 lag/ml bovine serum albumin (Bethesda Research Laboratories), 800 units/ml RNasin (Stratagene), 2.5 lag HindlII-linearized plasmid DNA and 35 units bacteriophage T7 RNA polymerase (Stratagene). Incubation was at 37 °C for 120 rain with the addition of 1.5 ~tl of 625 Ix~t-GTP after 30, 60 and 90 rain. For preparation of non-capped transcript, mVGpppG was omitted from the reaction mixture and the initial concentration of GTP was 500 ~ti. If desired, DNA was eliminated after completion of transcription by the addition of 6 units of RNase-free DNase (Stratagene) and incubation at 37 °C for 20 min. The amount and integrity of the synthesized transcript was usually evaluated by formaldehyde-agarose gel electrophoresis of 5 lal of a 100-fold dilution of the reaction mixture followed by transfer to nitrocellulose and Northern hybridization using 32P.labelled antisense RNA probes (Lemaire et aL, 1988) . If desired, the relative amounts of different transcripts were estimated by scintillation counting of radioactive regions excised from the nitrocellulose membrane.
Cell-free translation. Synthetic RNA-3 and RNA-4 transcripts to be used in translation experiments were freed of template DNA by DNase treatment, extracted with phenol/chloroform (1 : 1 v/v), precipitated from 70~ ethanol together with 10 gg calf liver carrier tRNA (Boehringer) and resuspended in sterile water at a transcript concentration of about 0-5 mg/ml. Cell-free translation in rabbit reticulocyte lysate and SDS-PAGE of the [3sS]methionine-labelled translation products were as described by Ziegler et al. (1985) .
Biological assay. For tests of transcript infectivity it was not necessary to eliminate the DNA template from the reaction mixture before inoculation. Freshly prepared RNA-3 transcript contained in 30 gl reaction mixture was diluted to 200 p.l with sterile water containing 0-05 ~ bentonite (Fraenkel-Conrat et aL, 1961) . RNA from BNYVV isolate G4, an isolate containing RNA-1, RNA-2 and a deleted RNA-4 but no RNA-3 (Lemaire et al., 1988) , was added to the mixture. The viral RNA was provided as a phenol extract of local lesions from C. quinoa leaves previously inoculated with isolate G4. Five celite-dusted C. quinoa leaves were each inoculated with 40 ~tl of the solution. Symptoms generally appeared 5 to 6 days after inoculation. Other experiments with RNA-3 and RNA-4 in vitro transcripts were carried out in a similar manner except that the transcript was co-inoculated with RNA of BNYVV isolate $5, which contained only BNYVV RNA-1 and RNA-2. BNYVV(S5) and BNYVV(S2) were isolated by T. Tamada (Hokkaido Central Agricultural Experiment Station, Naganuma, Hokkaido, Japan) and provided to us by L. J. Torrance (Scottish Crops Research Institute, Invergowrie, U.K.). BNYVV(F3) is described by Kuszala et al. (1986) . BNYVV RNA-3 and RNA-4 were purified from 0.5 ~ agarose-2.4~ polyacrylamide gels as described by Pinck & Fauquet (1975) .
RNA extraction and analysis. RNA was extracted from infected C. quinoa leaves 6 to 8 days after inoculation as described by Bouzoubaa et al. (1986) and analysed by formaldehyde-agarose gel electrophoresis (Gustafson et al., 1982) followed by transfer to nitrocellulose and hybridization with 32p-labelled antisense RNA probes (Zinn et al., 1983) specific for the various BNYVV RNAs (Lemaire et al., 1988) . For dot blot hybridization 50 ~tl of fourfold serial dilutions of RNA samples in 20 x SSC (3 M-NaCI, 0-3 M-sodium citrate) were deposited in duplicate on nitrocellulose using a HYBRI.DOT apparatus (Bethesda Research Laboratories). The membranes were washed quickly with 4 x SSC, baked under vacuum for 2 h at 80 °C and hybridized with 32p-labelled antisense RNA probes as described above. The 5' extremity of RNA-3 produced by infection with RNA-3 in vitro transcript or natural RNA-3 was characterized by primer extension with reverse transcriptase (Life Sciences, St Petersburg, Fla., U.S.A.) as described by Bouzoubaa et al. (1986) using the 5'-32p-labelled oligodeoxynucleotide ATCACCAACTGAGGG, which is complementary to nt 40 to 54 of RNA-3, as primer. The length of the resulting run-off cDNA was evaluated on an 8 ~ polyacrylamide sequencing gel.
RESULTS AND DISCUSSION
Synthetic transcripts of BNYVV Recombinant cDNA pBS(-) plasmids are designated according to the following nomenclature : pBXY (a-b) , where X is the BNYVV RNA component from which the cDNA originates, Y is an arbitrary plasmid identification number and a and b are the sequence coordinates of the cloned cDNA [exclusive of poly(A) tail] with respect to the RNA-3 or RNA-4 sequence (Bouzoubaa et al., 1985 . We have constructed a series of synthetic RNA-3 transcripts having identical 3'-terminal sequences but with Y-non-viral extensions of different lengths. BNYVV RNA-3 and RNA-4, like RNA-1 and RNA-2, possess 5'-terminal caps of mTGpppA and 3' poly(A) tails (Putz et al., 1983) . The three RNA-3 transcription vectors employed in this study, pB31 (2-1774), pB33(2-1774) and pB35(2-1774) contain the entire RNA-3 sequence except for the Y-terminal A residue and have a 3' poly(A) tail of about 110 nt. After linearization with HindlII and transcription with bacteriophage T7 RNA polymerase, all three vectors should produce run-off transcripts with 12 nt of extraneous non-viral sequence following the poly(A) tail at the 3' terminus ( Fig. 1) . At its 5' extremity, the transcript of pB35(2-1774), which we shall refer to as t35, should be identical to natural RNA-3 except that the Y-terminal A residue is replaced with G (Fig. 1) . The other two transcripts, t31 and t33, should possess 64 nt and 23 nt, respectively, of extraneous non-viral sequence separating the 5' terminus of the transcript from the RNA-3 sequence (Fig. 1) . Fig. 2 (a) presents an autoradiogram of the synthetic RNA-3 transcripts t31, t33 and t35, analysed by formaldehyde-agarose gel electrophoresis followed by Northern hybridization with a 32p.labelled probe specific for RNA-3. The amounts of t31 and t33 synthesized were generally about the same, corresponding to five to 10 copies per molecule of DNA template, t35, however, was synthesized with only one-tenth this efficiency (Fig. 2a) . The lower yield is presumably due to the divergence of the sequence at the 5' extremity of t35 from the consensus T7 polymerase initiation sequence defined with reference to natural bacteriophage T7 promoters (Dunn & Studier, 1983) as alterations in this sequence can diminish promoter activity (Ahlquist et al., 1987) . As will be shown below, however, the heightened biological activity of t35 compensates for this loss in transcription efficiency.
Incorporation of a cap structure at the 5' terminus of a synthetic transcript (Contreras et al., 1982) usually results in a marked enhancement of its biological activity (Ahlquist et al., 1984; Loesch-Fries et al., 1985; Dawson et al., 1986; Langereis et al., 1986) . Consequently, the transcripts used in this study were routinely synthesized in the presence of 500 ~tM-mTGpppG and a 25 p.i initial concentration of GTP, with additional aliquots of GTP provided during the course of the reaction. The extent of cap incorporation under these conditions has not been measured. Transcription of t35 was about three times more efficient when cap was omitted from the reaction mixture and a higher initial GTP concentration was used (Fig. 2a) but, as is shown below, this effect is offset by the lower biological activity of the non-capped transcripts. The synthetic RNA-4 transcript, t44, produced by T7 polymerase transcription of HindIIIlinearized pB44(2-1467), should possess a 12 nt non-viral extension at the 5' terminus and 28 nt of extraneous sequence following the poly(A) tail at the 3' terminus ( Fig. 1) . In formaldehydeagarose gels, t44 has a mobility slightly less than that of natural RNA-4 (Fig. 2b) . This difference is probably due, at least in part, to the presence of the non-viral sequence at the transcript extremities. It should also be noted, however, that the virion RNA preparation used to provide size markers in Fig. 2b is not from isolate F2 (which is no longer available), the isolate used to construct pB44(2-1467), and we cannot rule out the possibility that small isolate-dependent length variations in RNA-4 have occurred as has been demonstrated in other cases (Kuszala et al., 1986; Burgermeister et al., 1986) .
Cell-free translation of synthetic transcripts
BNYVV RNA-3 from virions directs synthesis of a 25 000 M, polypeptide and virion RNA-4 directs synthesis of a 31000 Mr polypeptide in rabbit reticulocyte lysates (Ziegler et al., 1985) ; this is in agreement with their predicted coding capacities (Bouzoubaa et al., 1985) . Fig. 3 shows that t33 and t44 have the same messenger activity as the natural RNA.
Biological activity of the transcripts
Freshly prepared transcription mixtures containing the RNA-3 transcript, the linearized parent plasmid and all the other ingredients were mechanically inoculated to leaves of C. quinoa 
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ii~:~i~j~ ~i~ ¸ ~ : al., 1988) . BNYVV(G4), like most other isolates deficient in RNA-3, produces large pale green local lesions on C. quinoa (Kuszala et al., 1986) (Fig. 4b) . When t31 and BNYVV(G4) RNA were inoculated together, a few bright yellow local lesions (between one and 14 per leaf, average 6.9) appeared among the pale green lesions (Fig. 4c) . Bright yellow local lesions of this sort are characteristic of the symptoms induced by isolates containing full-length RNA-3 (Kuszala et al., 1986) . Addition of t33 rather than t31 to the inoculum gave rise to about 10 times more of the bright yellow lesions (63 _+ 10 per leaf) (Fig. 4d) while addition of t35 converted virtually all the lesions to the bright yellow type (Fig. 4e) . Elimination of the plasmid D N A from the transcription mixture by DNase treatment before inoculation did not affect the results (data not shown). Inoculation with BNYVV(G4) RNA plus non-transcribed plasmid produced only the pale green local lesions characteristic of isolate G4 but inoculation of transcript alone produced no symptoms at all (data not shown).
The amount of BNYVV RNA-3 present in infected leaves such as those shown in Fig. 4 was estimated by dot blot hybridization. RNA was extracted from equal areas of leaf, immobilized on a nitrocellulose membrane and hybridized with either a 32p-labelled antisense RNA probe complementary to RNA-3 or a mixture of such probes complementary to RNA-1, RNA-2 and RNA-4. No RNA-3-specific sequence could be detected in RNA from leaf tissue inoculated separately with either BNYVV(G4) (Fig. 5 a, column 2) or with the RNA-3 transcript (data not shown) but RNA-3-specific sequence was synthesized when the two were inoculated together (Fig. 5 a, columns 3, 4 and 5) . As estimated from the intensity of the radioactive spots, there is an approx, fourfold increase in the amount of RNA-3 sequence present as each different transcript of the series t31, t33 and t35 is included in the inoculum (Fig. 5a, columns 3, 4 and 5) . It is evident that this result underestimates the biological activity of t35 relative to the other two transcripts because equal volumes of transcription mixture were inoculated in each case whereas, as noted above, t35 is transcribed about 10 times less efficiently than t31 and t33. Thus in this experiment, the specific biological activity of t35, defined as the amount of RNA-3-specific sequence produced per unit of inoculated transcript, was about 40-fold higher than for t33 and some 150-fold higher than for t31. Indeed, although a careful comparison has not been carried out, t35 appears to be approximately as active as native RNA-3. Finally, Fig. 5 (a) (columns 5 and 6) shows that the gain in transcription efficiency obtained by omitting the m7GpppG cap from the t35 transcription reaction is outweighed by the lower biological activity of the resulting non-capped transcript. The fiaechanism by which the 5'-non-viral sequences oft31 and t33 diminish their activity in these experiments is unknown. The 5'-non-coding region of authentic BNYVV RNA-3 is quite long, being 445 nt (Bouzoubaa et al., 1985 ). Thus we would not expect the relatively short 5' extensions characteristic of t31 and t33 (neither of which contains an AUG codon) to influence their translation greatly. Furthermore, t33 (Fig. 3 ) and t31 (data not shown) were translated in vitro with an efficiency comparable to that of natural RNA-3. A more plausible explanation is that the Y-non-viral extensions inhibit replication. If these sequences are copied during the first round of replication then the altered sequence context at the 3' extremity of the resulting minus strand could interfere with replicase recognition during subsequent plus strand synthesis. The 12 nt 3' extension following the transcript poly(A) tail, on the other hand, is apparently less detrimental, as judged by the approximately comparable activity of t35 and authentic RNA-3. Ahlquist et al. (1987) have reported similar findings with brome mosaic virus RNA-3 transcripts. The nature of the BNYVV RNA-3 molecules generated from the synthetic transcripts was investigated by Northern hybridization. R N A was extracted from 10 bright yellow lesions [or an equivalent area of leaf containing pale green lesions from leaves inoculated with BNYVV(G4) alone] and the viral R N A was visualized, after formaldehyde-agarose gel electrophoresis and transfer to nitrocellulose, by hybridization with 32p-labelled antisense R N A probes. Fig. 6 (a) reveals that the RNA-3 species produced by inoculation with t31, t33 and t35 are closely similar in size to one another and to virion RNA-3. Note that the relative intensities of the RNA-3 bands in the Northern blot do not reflect the overall abundance of RNA-3 in tissue infected with the different transcripts because only bright yellow local lesions characteristic of a BNYVV infection with RNA-3 were extracted in each case.
To test for the existence of residual non-viral sequence at the 5' extremity of the transcript progeny, RNA-3 produced by inoculation of t31 and t33 and natural RNA-3 were sized in a primer extension experiment. The primer was a 5' 3zp-labelled synthetic oligodeoxynucleotide complementary to nt 40 to 54 of RNA-3. After extension with reverse transcriptase the c D N A run-off copies are all of the same length (Fig. 7) . We conclude that the non-viral sequence present at the 5' terminus of t31 and t33 is eliminated during the viral replication cycle. It remains to be seen whether the Y-terminal residue in the transcript progeny has been corrected to A as in natural RNA-3 and if the polylinker sequence following the 3' poly(A) tail has been eliminated.
The biological activity of the RNA-4 transcript, t44, was tested in a similar fashion except that the transcript was co-inoculated with $5, a BNYVV isolate containing RNA-1 and RNA-2 but no detectable RNA-3 or RNA-4. Isolate $5 was used in preference to G4 because the deleted RNA-4 species present in the latter interferes with detection of t44 progeny in infected plants by dot blot hybridization. $5, like G4, produces faint pale green local lesions on C. quinoa. Addition of t44 to the inoculum did not result in obvious changes in these symptoms (data not shown). When RNA extracted from infected leaves was analysed by dot blot hybridization RNA-4-specific sequence was detected in leaves co-inoculated with BNYVV(S5) and t44 (Fig. 5b,  column 3) but not in those inoculated with t44 or BNYVV(S5) separately (Fig. 5b, columns 2 and  4) , or with BNYVV(S5) plus non-transcribed plasmid DNA (Fig. 5 b, column 1) . Fig. 6(b) shows that the size of the t44 progeny RNA in the leaves co-inoculated with $5 and t44 is about the same as that of natural RNA-4. The low intensity of the RNA-4 band in Fig. 6 (b) lane 2 compared to that of RNA-3 in Fig. 6 (a) lanes 2 to 4 does not necessarily signify that t44 is less infectious than the RNA-3 transcripts because, whereas in the latter case the extracted tissue was enriched for RNA-3 by selection of bright yellow local lesions, the presence of RNA-4 does not induce obvious symptom changes and the RNA loaded in Fig. 6 (b) lane 2 is not enriched by selection.
Concluding remarks
The results of these experiments provide evidence that the biological activities of synthetic BNYVV RNA-3 and RNA-4 transcripts, when co-inoculated with BNYVV isolates deficient in these RNAs, are comparable to those of virion RNA-3 and RNA-4. From the data presented above we cannot rule out the possibility that the transcripts do not undergo replication themselves but instead somehow act to amplify replication of traces of authentic RNA-3 and RNA-4 present in the co-inoculated BNYVV isolate. Such an explanation is unlikely in view of the different biological activities oft31, t33 and t35. These differences are readily rationalized in terms of the effect of 5'-non-viral extensions of different lengths on transcript replication but are much more difficult to account for in terms of a hypothetical protective effect of the transcript on contaminating RNA.
Additional evidence has come from experiments with RNA-3 transcripts containing engineered internal deletions. In one case pB35(2-1774) was altered by elimination of the 279 residue sequence between the BamHI and AccI sites of the insert (nt 756 to 1034) to produce pB35ABA. A second plasmid, pB35AEA, was produced by elimination of 553 nt between the EcoRI and AccI sites of the insert (nt 482 to 1034). Run-off transcripts of each of these plasmids were biologically active when co-inoculated with BNYVV(S5) (Fig. 8) . Furthermore the lengths of the newly synthesized RNA-3 extracted from the infected leaves reflect the lengths of the deleted transcripts added to the inoculum, providing additional strong evidence that the progeny RNA-3 molecules arise from replication of the transcripts. It is evident that modified transcripts such as these will be useful in identifying structural features important for RNA replication and encapsidation and in defining the role(s) of BNYVV RNA-3 and RNA-4 in the infection process.
